Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1330537

registered interest
date	08/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	What recent assessment he has made of the progress of the covid-19 vaccine rollout programme across the UK.
tabling member constituency	Stoke-on-Trent North
tabling member printed	Jonathan Gullis
uin	900838
answer	answer is ministerial correction date of answer 08/06/2021 answer text <p>We have administered over 60 million vaccine jabs in the United Kingdom, with 75% of the adult population already having received their first dose. Over 25 million people have now received their second dose and</p><p>53% of people aged 30 to 39 years have received at least one dose since the programme began opening up to the age group on 13 May. This week, we will open the vaccination programme to ages 25 to 29 years old.</p><p>We are on track to meet our vaccination target to offer all adults a vaccine by the end of July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/06/2021 16:30:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4814 label Biography information for Jonathan Gullis

1330540

registered interest
date	08/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	What recent progress has been made on vaccinating people against covid-19.
tabling member constituency	New Forest West
tabling member printed	Sir Desmond Swayne
uin	900845
answer	answer is ministerial correction date of answer 08/06/2021 answer text <p>We have administered over 60 million vaccine jabs in the United Kingdom, with 75% of the adult population already having received their first dose. Over 25 million people have now received their second dose and</p><p>53% of people aged 30 to 39 years have received at least one dose since the programme began opening up to the age group on 13 May. This week, we will open the vaccination programme to ages 25 to 29 years old.</p><p>We are on track to meet our vaccination target to offer all adults a vaccine by the end of July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/06/2021 16:31:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	55 label Biography information for Sir Desmond Swayne

1329962

registered interest
date	07/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 May 2021 to Question 1312 on Coronavirus: Vaccination, what information has NHS England provided to the local authority Director of Public Health on the number of (a) covid-19 vaccinations that have been administered and (b) people eligible for those vaccinations, by ethnicity, for each of the wards in Waltham Forest where that information is available for the last five months.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	11542
answer	answer is ministerial correction date of answer 17/06/2021 answer text <p>From 15 January to 23 April, Public Health England (PHE) facilitated access for Directors of Public Health to local level data provided by NHS England and NHS Improvement via its secure platform. Since 23 April 2021, these data have been provided directly by PHE.</p><p> </p><p>PHE provides daily COVID-19 vaccine data to Directors of Public Health in England, including for Waltham Forest. These data include breakdowns to lower super output area (LSOA) level by age, sex and ethnicity. LSOA data can be aggregated to ward level.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 17/06/2021 15:25:49 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 5549 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4088 label Biography information for Stella Creasy

1330137

registered interest
date	07/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Infrastructure: Iron and Steel
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how much UK-produced steel reinforcing bar was procured for Government-funded infrastructure projects in each of the last three years.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	11567
answer	answer is ministerial correction date of answer 10/06/2021 answer text <p>The Department for Business, Energy and Industrial Strategy (BEIS) collates and publishes annually information on how much steel is purchased for the Government’s major infrastructure projects in the previous financial year, including what proportion is produced in the UK. This year’s data was published on 19 May and can be found at: <a href="http://www.gov.uk/government/publications/steel-public-procurement-2021" target="_blank">www.gov.uk/government/publications/steel-public-procurement-2021</a>.</p><p> </p><p>The reported value of UK steel procured in 2019/20 for major public projects was £108m, a 33% increase on the previous year. BEIS will start collating data for 2020/21 in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/06/2021 14:28:51 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1330246

registered interest
date	07/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on (a) the efficacy of the Novavax vaccine following its trial and (b) whether volunteers who received two vaccinations as part of the Novavax trial are eligible to receive other types of approved covid-19 vaccines.
tabling member constituency	Rochdale
tabling member printed	Tony Lloyd
uin	11480
answer	answer is ministerial correction date of answer 09/07/2021 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has regular meetings with Novavax regarding their submission for the vaccine but this is not yet complete. A review of the quality, safety and efficacy data will be required before the MHRA and Commission on Human Medicines can consider approval of the vaccine.</p><p>As trial participants become eligible for the vaccination programme, they should discuss with the trial investigator to decide whether they should receive an approved COVID-19 vaccine. This should be informed by whether they had received a placebo or control vaccine, an active vaccine with known efficacy against COVID-19, an experimental trial vaccine product with no current efficacy data and whether they have received a full proposed or incomplete regimen. There is currently a lack of evidence to inform whether a subsequent dose of a different COVID-19 vaccine after a full regimen of experimental vaccine provides any benefit. Subjects should also be made aware that the risks of receiving the deployed vaccine after the trial vaccine are unknown.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/07/2021 13:16:02 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 5548 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	450 label Biography information for Tony Lloyd

1329368

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the merits of prioritising clinically extremely vulnerable children for a covid-19 vaccine if licensed for use in children.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	10529
answer	answer is ministerial correction date of answer 10/06/2021 answer text <p>The Pfizer/BioNTech vaccine has now been authorised by the Medicines and Healthcare products Regulatory Agency for use in children aged 12 to 15 years old in the United Kingdom. The Government will now be guided by the advice of experts, including the Joint Committee on Vaccination and Immunisation (JCVI), on any potential routine deployment of COVID-19 vaccination in children.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/06/2021 15:43:27 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1329378

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of successful applications from volunteer vaccinators who have not been deployed during the covid-19 vaccine rollout.
tabling member constituency	West Worcestershire
tabling member printed	Harriett Baldwin
uin	10374
answer	answer is ministerial correction date of answer 14/06/2021 answer text <p>Working in partnership with St John Ambulance and the Royal Voluntary Service, 420,000 volunteers have been deployed to help support the COVID-19 vaccine programme. St John Ambulance holds the only nationally procured contract for volunteer vaccinators and of the 26,858 individuals recruited to support the vaccination programme in partnership with St John Ambulance, approximately 11,510 of these volunteers have not yet been deployed.</p><p>NHS England and NHS Improvement do not hold any personal data on volunteers within the vaccination programme sourced through the national supply chain contracts. Lead employers would retain the information of locally sourced volunteers and this would be the responsibility of an individual organisation. The data controller is St John Ambulance or the Royal Voluntary Service and all data received to the national programme team is anonymised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 10375 question first answered 14/06/2021 09:36:57 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4107 label Biography information for Dame Harriett Baldwin

1329379

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how long the personal information and references provided by volunteer covid-19 vaccinator applicants will be retained by the National Vaccination Programme.
tabling member constituency	West Worcestershire
tabling member printed	Harriett Baldwin
uin	10375
answer	answer is ministerial correction date of answer 14/06/2021 answer text <p>Working in partnership with St John Ambulance and the Royal Voluntary Service, 420,000 volunteers have been deployed to help support the COVID-19 vaccine programme. St John Ambulance holds the only nationally procured contract for volunteer vaccinators and of the 26,858 individuals recruited to support the vaccination programme in partnership with St John Ambulance, approximately 11,510 of these volunteers have not yet been deployed.</p><p>NHS England and NHS Improvement do not hold any personal data on volunteers within the vaccination programme sourced through the national supply chain contracts. Lead employers would retain the information of locally sourced volunteers and this would be the responsibility of an individual organisation. The data controller is St John Ambulance or the Royal Voluntary Service and all data received to the national programme team is anonymised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 10374 question first answered 14/06/2021 09:36:57 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4107 label Biography information for Dame Harriett Baldwin

1329404

registered interest
date	04/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether advanced orders placed for new covid-19 vaccines such as the Janseen vaccine will be designed around the latest variants known to be in existence at the time of delivery.
tabling member constituency	Lichfield
tabling member printed	Michael Fabricant
uin	10158
answer	answer is ministerial correction date of answer 14/06/2021 answer text <p>The UK Government has secured early access to 397 million vaccines doses through supply agreements with six separate vaccine developers. This includes agreements with:</p><p> </p><ul><li>Pfizer/BioNTech for 100 million doses</li><li>University of Oxford/AstraZeneca for 100 million doses</li><li>Moderna for 17 million doses</li><li>Novavax for 60 million doses</li><li>Janssen for 20 million doses</li><li>Valneva for 100 million doses</li></ul><p> </p><p>In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.</p><p> </p><p>The Government is working closely with vaccine manufacturers and Public Health England to understand the efficacy of our current vaccine portfolio against new variants and will continue to monitor the picture with variants as it develops. <br> <br> The Government announced on 3 June 2021 that it has started commercial negotiations with AstraZeneca for future supplies of the University of Oxford/AstraZeneca vaccine that have been adapted to tackle the Beta variant first identified in South Africa.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/06/2021 15:23:17 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	280 label Biography information for Michael Fabricant

1329432

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 May 2021 to Question 6161 on the vaccination status of people hospitalised with the Indian variant of covid-19, for what reason those essential data are not held centrally in the format requested; in what format those data are held centrally; and if he will make it his policy without further delay to (a) gather centrally and (b) subsequently release to the media each day the numbers of people that have been hospitalised with the Indian variant of covid-19 who are (i) vaccinated with (A) one and (B) both doses and (ii) unvaccinated against coronavirus.
tabling member constituency	New Forest East
tabling member printed	Dr Julian Lewis
uin	10131
answer	answer is ministerial correction date of answer 26/07/2021 answer text <p>Data concerning the numbers of people hospitalised with the Delta variant who have received one dose, two doses and are unvaccinated is collected centrally for inclusion in Public Health England’s (PHE) ‘Investigation of SARS-CoV-2 variants of concern: technical briefings’ which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201" target="_blank">https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201</a></p><p>This data was first included on 27 May and form part of ongoing surveillance and vaccine effectiveness monitoring activity. Public Health England collates data on COVID-19 cases, hospitalisations and COVID-19 vaccination status from a number of different data sources, including the Office for National Statistics, National Health Service trusts, private laboratories and Lighthouse Laboratories There are currently no plans to provide daily statistics due to varying reporting timelines of the data sources.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/07/2021 16:17:49 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 5147 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	54 label Biography information for Sir Julian Lewis